TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Agonist activity at rat CB2 receptor assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 11nMAssay Description:Agonist activity at human recombinant CB2 receptor expressing CHO cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 3...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: >2.00E+4nMAssay Description:Agonist activity at rat CB1 receptor assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Boehringer Ingelheim Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: >2.00E+4nMAssay Description:Agonist activity at human recombinant CB1 receptor expressing CHO cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 3...More data for this Ligand-Target Pair